185 related articles for article (PubMed ID: 21481923)
21. Involvement of Heparanase in early pregnancy losses.
Nadir Y; Henig I; Naroditzky I; Paz B; Vlodavsky I; Brenner B
Thromb Res; 2010 May; 125(5):e251-7. PubMed ID: 20031192
[TBL] [Abstract][Full Text] [Related]
22. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
23. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation.
Adams M; Breckler L; Stevens P; Thom J; Baker R; Oostryck R
Haematologica; 2004 Aug; 89(8):985-90. PubMed ID: 15339683
[TBL] [Abstract][Full Text] [Related]
24. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
25. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of tissue factor procoagulant activity on the surface of feline leukocytes in response to treatment with lipopolysaccharide and heat-inactivated fetal bovine serum.
Stokol T; Daddona JL; Choi B
Am J Vet Res; 2010 Jun; 71(6):623-9. PubMed ID: 20513176
[TBL] [Abstract][Full Text] [Related]
27. [Tissue factor pathway inhibitors].
Sierko E; Zawadzki RJ; Wojtukiewicz MZ
Pol Merkur Lekarski; 2002 Jul; 13(73):66-9. PubMed ID: 12362512
[TBL] [Abstract][Full Text] [Related]
28. Heparanase in the Coagulation System.
Nadir Y
Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
[TBL] [Abstract][Full Text] [Related]
29. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus.
Leurs PB; van Oerle R; Wolffenbuttel BH; Hamulyak K
Thromb Haemost; 1997 Mar; 77(3):472-6. PubMed ID: 9065996
[TBL] [Abstract][Full Text] [Related]
30. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
31. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
[TBL] [Abstract][Full Text] [Related]
32. Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation.
Peled E; Melamed E; Portal TB; Axelman E; Norman D; Brenner B; Nadir Y
Thromb Res; 2016 Mar; 139():148-53. PubMed ID: 26916313
[TBL] [Abstract][Full Text] [Related]
33. Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis.
Lindström OK; Tukiainen EM; Kylänpää ML; Mentula PJ; Puolakkainen PA; Wartiovaara-Kautto UM; Repo H; Petäjä JM
Pancreatology; 2011; 11(6):557-66. PubMed ID: 22213026
[TBL] [Abstract][Full Text] [Related]
34. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
35. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
36. Procoagulant activity and phosphatidylserine of amniotic fluid cells.
Zhou J; Liu S; Ma M; Hou J; Yu H; Lu C; Gilbert GE; Shi J
Thromb Haemost; 2009 May; 101(5):845-51. PubMed ID: 19404537
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy.
Ittel A; Bretelle F; Gris JC; Chau C; Sébahoun G; Boubli L; Arnoux D
Thromb Haemost; 2011 Jan; 105(1):66-71. PubMed ID: 20978710
[TBL] [Abstract][Full Text] [Related]
38. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
39. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
40. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
